Intrinsic value of Hill-Rom Holdings - HRC

Previous Close

$96.54

  Intrinsic Value

$51.94

stock screener

  Rating & Target

sell

-46%

Previous close

$96.54

 
Intrinsic value

$51.94

 
Up/down potential

-46%

 
Rating

sell

We calculate the intrinsic value of HRC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 6.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.80
  3.02
  3.22
  3.40
  3.56
  3.70
  3.83
  3.95
  4.05
  4.15
  4.23
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.63
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.82
  4.84
  4.86
  4.87
  4.88
  4.90
Revenue, $m
  2,821
  2,906
  2,999
  3,101
  3,211
  3,330
  3,458
  3,594
  3,740
  3,895
  4,060
  4,235
  4,420
  4,617
  4,824
  5,044
  5,275
  5,520
  5,777
  6,049
  6,335
  6,637
  6,954
  7,289
  7,640
  8,010
  8,399
  8,808
  9,239
  9,691
Variable operating expenses, $m
  1,433
  1,468
  1,506
  1,547
  1,592
  1,640
  1,691
  1,747
  1,806
  1,869
  1,645
  1,716
  1,791
  1,871
  1,955
  2,044
  2,137
  2,236
  2,341
  2,451
  2,567
  2,689
  2,818
  2,953
  3,096
  3,245
  3,403
  3,569
  3,743
  3,927
Fixed operating expenses, $m
  1,114
  1,138
  1,164
  1,189
  1,215
  1,242
  1,269
  1,297
  1,326
  1,355
  1,385
  1,415
  1,446
  1,478
  1,511
  1,544
  1,578
  1,613
  1,648
  1,684
  1,721
  1,759
  1,798
  1,838
  1,878
  1,919
  1,962
  2,005
  2,049
  2,094
Total operating expenses, $m
  2,547
  2,606
  2,670
  2,736
  2,807
  2,882
  2,960
  3,044
  3,132
  3,224
  3,030
  3,131
  3,237
  3,349
  3,466
  3,588
  3,715
  3,849
  3,989
  4,135
  4,288
  4,448
  4,616
  4,791
  4,974
  5,164
  5,365
  5,574
  5,792
  6,021
Operating income, $m
  273
  300
  330
  365
  405
  449
  497
  550
  608
  672
  1,030
  1,104
  1,183
  1,268
  1,359
  1,456
  1,560
  1,671
  1,788
  1,914
  2,047
  2,188
  2,339
  2,498
  2,667
  2,845
  3,035
  3,235
  3,447
  3,671
EBITDA, $m
  624
  652
  685
  722
  764
  810
  861
  918
  979
  1,045
  1,117
  1,194
  1,278
  1,367
  1,462
  1,564
  1,673
  1,789
  1,912
  2,043
  2,183
  2,331
  2,487
  2,654
  2,830
  3,017
  3,214
  3,423
  3,644
  3,878
Interest expense (income), $m
  81
  125
  129
  135
  141
  147
  154
  161
  169
  178
  187
  196
  207
  218
  229
  241
  254
  268
  283
  298
  314
  331
  349
  367
  387
  408
  430
  453
  477
  503
  530
Earnings before tax, $m
  149
  170
  195
  225
  258
  295
  336
  381
  431
  485
  834
  897
  965
  1,039
  1,117
  1,202
  1,292
  1,388
  1,491
  1,600
  1,716
  1,840
  1,971
  2,111
  2,258
  2,415
  2,581
  2,757
  2,944
  3,141
Tax expense, $m
  40
  46
  53
  61
  70
  80
  91
  103
  116
  131
  225
  242
  261
  280
  302
  324
  349
  375
  402
  432
  463
  497
  532
  570
  610
  652
  697
  744
  795
  848
Net income, $m
  109
  124
  143
  164
  188
  215
  245
  278
  314
  354
  609
  655
  705
  758
  816
  877
  943
  1,013
  1,088
  1,168
  1,253
  1,343
  1,439
  1,541
  1,649
  1,763
  1,884
  2,013
  2,149
  2,293

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  4,654
  4,795
  4,949
  5,117
  5,299
  5,495
  5,706
  5,931
  6,172
  6,428
  6,700
  6,988
  7,294
  7,618
  7,961
  8,323
  8,705
  9,108
  9,534
  9,982
  10,454
  10,952
  11,476
  12,027
  12,608
  13,218
  13,860
  14,535
  15,245
  15,992
Adjusted assets (=assets-cash), $m
  4,654
  4,795
  4,949
  5,117
  5,299
  5,495
  5,706
  5,931
  6,172
  6,428
  6,700
  6,988
  7,294
  7,618
  7,961
  8,323
  8,705
  9,108
  9,534
  9,982
  10,454
  10,952
  11,476
  12,027
  12,608
  13,218
  13,860
  14,535
  15,245
  15,992
Revenue / Adjusted assets
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
  0.606
Average production assets, $m
  1,811
  1,865
  1,925
  1,991
  2,062
  2,138
  2,220
  2,308
  2,401
  2,501
  2,606
  2,719
  2,838
  2,964
  3,097
  3,238
  3,387
  3,544
  3,709
  3,884
  4,067
  4,261
  4,465
  4,679
  4,905
  5,142
  5,392
  5,655
  5,931
  6,222
Working capital, $m
  477
  491
  507
  524
  543
  563
  584
  607
  632
  658
  686
  716
  747
  780
  815
  852
  892
  933
  976
  1,022
  1,071
  1,122
  1,175
  1,232
  1,291
  1,354
  1,419
  1,489
  1,561
  1,638
Total debt, $m
  2,397
  2,495
  2,603
  2,721
  2,848
  2,986
  3,133
  3,291
  3,459
  3,638
  3,829
  4,031
  4,245
  4,472
  4,711
  4,965
  5,232
  5,515
  5,812
  6,126
  6,457
  6,805
  7,172
  7,558
  7,964
  8,391
  8,841
  9,314
  9,811
  10,333
Total liabilities, $m
  3,258
  3,356
  3,464
  3,582
  3,709
  3,847
  3,994
  4,152
  4,320
  4,499
  4,690
  4,892
  5,106
  5,333
  5,573
  5,826
  6,094
  6,376
  6,674
  6,987
  7,318
  7,666
  8,033
  8,419
  8,825
  9,253
  9,702
  10,175
  10,672
  11,194
Total equity, $m
  1,396
  1,438
  1,485
  1,535
  1,590
  1,649
  1,712
  1,779
  1,851
  1,928
  2,010
  2,097
  2,188
  2,285
  2,388
  2,497
  2,612
  2,732
  2,860
  2,995
  3,136
  3,286
  3,443
  3,608
  3,782
  3,965
  4,158
  4,361
  4,574
  4,798
Total liabilities and equity, $m
  4,654
  4,794
  4,949
  5,117
  5,299
  5,496
  5,706
  5,931
  6,171
  6,427
  6,700
  6,989
  7,294
  7,618
  7,961
  8,323
  8,706
  9,108
  9,534
  9,982
  10,454
  10,952
  11,476
  12,027
  12,607
  13,218
  13,860
  14,536
  15,246
  15,992
Debt-to-equity ratio
  1.720
  1.730
  1.750
  1.770
  1.790
  1.810
  1.830
  1.850
  1.870
  1.890
  1.900
  1.920
  1.940
  1.960
  1.970
  1.990
  2.000
  2.020
  2.030
  2.050
  2.060
  2.070
  2.080
  2.090
  2.110
  2.120
  2.130
  2.140
  2.150
  2.150
Adjusted equity ratio
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  109
  124
  143
  164
  188
  215
  245
  278
  314
  354
  609
  655
  705
  758
  816
  877
  943
  1,013
  1,088
  1,168
  1,253
  1,343
  1,439
  1,541
  1,649
  1,763
  1,884
  2,013
  2,149
  2,293
Depreciation, amort., depletion, $m
  351
  353
  355
  357
  359
  362
  364
  367
  370
  374
  87
  91
  95
  99
  103
  108
  113
  118
  124
  129
  136
  142
  149
  156
  163
  171
  180
  189
  198
  207
Funds from operations, $m
  459
  477
  497
  521
  547
  577
  610
  646
  685
  728
  696
  745
  799
  857
  919
  985
  1,056
  1,131
  1,212
  1,297
  1,388
  1,485
  1,588
  1,697
  1,812
  1,935
  2,064
  2,201
  2,347
  2,500
Change in working capital, $m
  13
  14
  16
  17
  19
  20
  22
  23
  25
  26
  28
  30
  31
  33
  35
  37
  39
  41
  44
  46
  48
  51
  54
  56
  59
  63
  66
  69
  73
  76
Cash from operations, $m
  446
  462
  481
  503
  529
  557
  588
  622
  660
  701
  668
  716
  768
  824
  884
  948
  1,017
  1,090
  1,168
  1,251
  1,340
  1,434
  1,534
  1,640
  1,753
  1,872
  1,998
  2,132
  2,274
  2,424
Maintenance CAPEX, $m
  -59
  -60
  -62
  -64
  -66
  -69
  -71
  -74
  -77
  -80
  -83
  -87
  -91
  -95
  -99
  -103
  -108
  -113
  -118
  -124
  -129
  -136
  -142
  -149
  -156
  -163
  -171
  -180
  -189
  -198
New CAPEX, $m
  -50
  -55
  -60
  -65
  -71
  -76
  -82
  -88
  -94
  -100
  -106
  -112
  -119
  -126
  -133
  -141
  -149
  -157
  -165
  -174
  -184
  -194
  -204
  -215
  -226
  -238
  -250
  -263
  -276
  -290
Cash from investing activities, $m
  -109
  -115
  -122
  -129
  -137
  -145
  -153
  -162
  -171
  -180
  -189
  -199
  -210
  -221
  -232
  -244
  -257
  -270
  -283
  -298
  -313
  -330
  -346
  -364
  -382
  -401
  -421
  -443
  -465
  -488
Free cash flow, $m
  337
  347
  359
  374
  391
  412
  435
  461
  490
  522
  478
  517
  558
  603
  652
  704
  760
  820
  885
  953
  1,027
  1,105
  1,188
  1,277
  1,371
  1,471
  1,577
  1,690
  1,809
  1,936
Issuance/(repayment) of debt, $m
  88
  98
  108
  118
  127
  137
  147
  158
  168
  179
  190
  202
  214
  227
  240
  253
  268
  282
  298
  314
  331
  348
  367
  386
  406
  427
  449
  473
  497
  523
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  88
  98
  108
  118
  127
  137
  147
  158
  168
  179
  190
  202
  214
  227
  240
  253
  268
  282
  298
  314
  331
  348
  367
  386
  406
  427
  449
  473
  497
  523
Total cash flow (excl. dividends), $m
  425
  446
  467
  492
  519
  549
  582
  619
  658
  701
  669
  719
  772
  830
  892
  957
  1,028
  1,103
  1,182
  1,267
  1,357
  1,453
  1,555
  1,663
  1,777
  1,898
  2,027
  2,162
  2,306
  2,458
Retained Cash Flow (-), $m
  -38
  -42
  -46
  -50
  -55
  -59
  -63
  -68
  -72
  -77
  -82
  -87
  -92
  -97
  -103
  -109
  -115
  -121
  -128
  -135
  -142
  -149
  -157
  -165
  -174
  -183
  -193
  -203
  -213
  -224
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  387
  404
  421
  441
  464
  490
  519
  551
  586
  624
  587
  632
  681
  733
  789
  849
  913
  982
  1,055
  1,133
  1,216
  1,304
  1,398
  1,497
  1,603
  1,715
  1,834
  1,960
  2,093
  2,234
Discount rate, %
  8.70
  9.14
  9.59
  10.07
  10.57
  11.10
  11.66
  12.24
  12.85
  13.50
  14.17
  14.88
  15.62
  16.41
  17.23
  18.09
  18.99
  19.94
  20.94
  21.98
  23.08
  24.24
  25.45
  26.72
  28.06
  29.46
  30.93
  32.48
  34.11
  35.81
PV of cash for distribution, $m
  356
  339
  320
  300
  281
  261
  240
  219
  197
  176
  137
  120
  103
  87
  73
  59
  48
  37
  28
  21
  16
  11
  8
  5
  3
  2
  1
  1
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company's products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.

FINANCIAL RATIOS  of  Hill-Rom Holdings (HRC)

Valuation Ratios
P/E Ratio 47.4
Price to Sales 2.3
Price to Book 4.7
Price to Tangible Book
Price to Cash Flow 20.4
Price to Free Cash Flow 29.8
Growth Rates
Sales Growth Rate 3.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 18.1%
Cap. Spend. - 3 Yr. Gr. Rate 9.2%
Financial Strength
Quick Ratio 1
Current Ratio 0.1
LT Debt to Equity 156.1%
Total Debt to Equity 170%
Interest Coverage 3
Management Effectiveness
Return On Assets 4.4%
Ret/ On Assets - 3 Yr. Avg. 3.5%
Return On Total Capital 3.8%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 10.4%
Return On Equity - 3 Yr. Avg. 8.6%
Asset Turnover 0.6
Profitability Ratios
Gross Margin 48.1%
Gross Margin - 3 Yr. Avg. 46.6%
EBITDA Margin 17.3%
EBITDA Margin - 3 Yr. Avg. 14.3%
Operating Margin 10%
Oper. Margin - 3 Yr. Avg. 7.5%
Pre-Tax Margin 6.7%
Pre-Tax Margin - 3 Yr. Avg. 5%
Net Profit Margin 4.9%
Net Profit Margin - 3 Yr. Avg. 4%
Effective Tax Rate 27.9%
Eff/ Tax Rate - 3 Yr. Avg. 22.1%
Payout Ratio 35.1%

HRC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the HRC stock intrinsic value calculation we used $2743.7 million for the last fiscal year's total revenue generated by Hill-Rom Holdings. The default revenue input number comes from 0001 income statement of Hill-Rom Holdings. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our HRC stock valuation model: a) initial revenue growth rate of 2.8% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8.7%, whose default value for HRC is calculated based on our internal credit rating of Hill-Rom Holdings, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Hill-Rom Holdings.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of HRC stock the variable cost ratio is equal to 51.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1090 million in the base year in the intrinsic value calculation for HRC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Hill-Rom Holdings.

Corporate tax rate of 27% is the nominal tax rate for Hill-Rom Holdings. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the HRC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for HRC are equal to 64.2%.

Life of production assets of 30.9 years is the average useful life of capital assets used in Hill-Rom Holdings operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for HRC is equal to 16.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1358.2 million for Hill-Rom Holdings - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 66.405 million for Hill-Rom Holdings is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Hill-Rom Holdings at the current share price and the inputted number of shares is $6.4 billion.

RELATED COMPANIES Price Int.Val. Rating
SYK Stryker 172.61 100.38  sell
IVC Invacare 5.22 7.95  str.sell
ELMD Electromed 5.50 3.00  sell
STE Steris 117.01 40.68  str.sell

COMPANY NEWS

▶ Hospital Beds Get Digital Upgrade   [Dec-09-18 07:33PM  The Wall Street Journal]
▶ Hospital Beds Get Digital Upgrade   [11:48AM  The Wall Street Journal]
▶ Hill-Rom Announces Executive Appointments   [Nov-27-18 06:58AM  PR Newswire]
▶ Hill-Rom Declares Fiscal 2019 First Quarter Dividend   [Nov-07-18 04:05PM  PR Newswire]
▶ Hill-Rom: Fiscal 4Q Earnings Snapshot   [07:42AM  Associated Press]
▶ What is Behind Hill-Rom Holdings Incs (NYSE:HRC) Superior ROE?   [Sep-25-18 08:34AM  Simply Wall St.]
▶ HRC World PLC: NOTICE OF ANNUAL GENERAL MEETING   [Jul-30-18 12:47PM  GlobeNewswire]
▶ HRC World PLC: CHANGE IN OPERATING STRUCTURE   [07:19AM  GlobeNewswire]
▶ Is Hill-Rom (HRC) Stock Undervalued Right Now?   [Jul-25-18 11:51AM  Zacks]
▶ HRC World PLC: FINANCIAL RESULTS TO 31 MARCH 2018   [Jul-23-18 05:09AM  GlobeNewswire]
▶ Hill-Rom Declares Fiscal 2018 Fourth Quarter Dividend   [Jul-18-18 04:05PM  PR Newswire]
▶ Should You Buy Hill-Rom Holdings Inc (NYSE:HRC)?   [Jun-22-18 09:05AM  Simply Wall St.]
▶ Who Really Owns Grupa HRC Spolka Akcyjna (WSE:HRC)?   [May-15-18 02:39AM  Simply Wall St.]
▶ Hill-Rom Declares Fiscal 2018 Third Quarter Dividend   [May-10-18 06:55AM  PR Newswire]
▶ Hill-Rom: Fiscal 2Q Earnings Snapshot   [07:07AM  Associated Press]
▶ Earnings Outlook For Hill-Rom Holdings   [Apr-26-18 02:28PM  Benzinga]
▶ Calculating The Fair Value Of Hill-Rom Holdings Inc (NYSE:HRC)   [Mar-18-18 10:30AM  Simply Wall St.]
▶ HRC WORLD PLC: LAUNCHING OF HRC MUSIC   [04:01AM  GlobeNewswire]
▶ Hill-Rom Raises Quarterly Dividend   [Mar-07-18 06:55AM  PR Newswire]
▶ 5 Best PEG Stocks Value Investors Love   [Feb-09-18 09:51AM  Zacks]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.